Hui Xu1, Rongrong Yang1, Xiuying Qi1, Christina Dintica2, Ruixue Song1, David A Bennett3, Weili Xu1,2. 1. Department of Epidemiology and Biostatistics, School of Public Health, Tianjin Medical University, Tianjin, China. 2. Aging Research Center, Department of Neurobiology, Care Sciences and Society, Karolinska Institutet and Stockholm University, Stockholm, Sweden. 3. Rush Alzheimer's Disease Center, Rush University Medical Center, Chicago, Illinois.
Abstract
IMPORTANCE: Evidence on the association of lifespan cognitive reserve (CR) with dementia is limited, and the strength of this association in the presence of brain pathologies is unknown. OBJECTIVE: To examine the association of lifespan CR with dementia risk, taking brain pathologies into account. DESIGN, SETTING, AND PARTICIPANTS: This study used data from 2022 participants in the Rush Memory and Aging Project, an ongoing community-based cohort study with annual follow-up from 1997 to 2018 (mean follow-up, 6 years; maximum follow-up, 20 years). After excluding 420 individuals who had prevalent dementia, missing data on CR, or dropped out, 1602 dementia-free adults were identified at baseline and evaluated to detect incident dementia. During follow-up, 611 died and underwent autopsies. Data were analyzed from May to September 2018. EXPOSURES: Information on CR factors (education; early-life, midlife, and late-life cognitive activities; and social activities in late life) was obtained at baseline. Based on these factors, lifespan CR scores were captured using a latent variable from a structural equation model and was divided into tertiles (lowest, middle, and highest). MAIN OUTCOMES AND MEASURES: Dementia was diagnosed following international criteria. Neuropathologic evaluations for Alzheimer disease and other brain pathologies were performed in autopsied participants. The association of lifespan CR with dementia or brain pathologies was estimated using Cox regression models or logistic regression. RESULTS: Of the 1602 included participants, 1216 (75.9%) were women, and the mean (SD) age was 79.6 (7.5) years. During follow-up, 386 participants developed dementia (24.1%), including 357 participants with Alzheimer disease-related dementia (22.3%). The multiadjusted hazards ratios (HRs) of dementia were 0.77 (95% CI, 0.59-0.99) for participants in the middle CR score tertile and 0.61 (95% CI, 0.47-0.81) for those in the highest CR score tertile compared with those in the lowest CR score tertile. In autopsied participants, CR was not associated with most brain pathologies, and the association of CR with dementia remained significant after additional adjustment for brain pathologies (HR, 0.60; 95% CI, 0.42-0.86). The highest CR score tertile was associated with a reduction in dementia risk, even among participants with high Alzheimer disease pathology (HR, 0.57; 95% CI, 0.37-0.87) and any gross infarcts (HR, 0.34; 95% CI, 0.18-0.62). CONCLUSIONS AND RELEVANCE: High lifespan CR is associated with a reduction in dementia risk, even in the presence of high brain pathologies. Our findings highlight the importance of lifespan CR accumulation in dementia prevention.
IMPORTANCE: Evidence on the association of lifespan cognitive reserve (CR) with dementia is limited, and the strength of this association in the presence of brain pathologies is unknown. OBJECTIVE: To examine the association of lifespan CR with dementia risk, taking brain pathologies into account. DESIGN, SETTING, AND PARTICIPANTS: This study used data from 2022 participants in the Rush Memory and Aging Project, an ongoing community-based cohort study with annual follow-up from 1997 to 2018 (mean follow-up, 6 years; maximum follow-up, 20 years). After excluding 420 individuals who had prevalent dementia, missing data on CR, or dropped out, 1602 dementia-free adults were identified at baseline and evaluated to detect incident dementia. During follow-up, 611 died and underwent autopsies. Data were analyzed from May to September 2018. EXPOSURES: Information on CR factors (education; early-life, midlife, and late-life cognitive activities; and social activities in late life) was obtained at baseline. Based on these factors, lifespan CR scores were captured using a latent variable from a structural equation model and was divided into tertiles (lowest, middle, and highest). MAIN OUTCOMES AND MEASURES: Dementia was diagnosed following international criteria. Neuropathologic evaluations for Alzheimer disease and other brain pathologies were performed in autopsied participants. The association of lifespan CR with dementia or brain pathologies was estimated using Cox regression models or logistic regression. RESULTS: Of the 1602 included participants, 1216 (75.9%) were women, and the mean (SD) age was 79.6 (7.5) years. During follow-up, 386 participants developed dementia (24.1%), including 357 participants with Alzheimer disease-related dementia (22.3%). The multiadjusted hazards ratios (HRs) of dementia were 0.77 (95% CI, 0.59-0.99) for participants in the middle CR score tertile and 0.61 (95% CI, 0.47-0.81) for those in the highest CR score tertile compared with those in the lowest CR score tertile. In autopsied participants, CR was not associated with most brain pathologies, and the association of CR with dementia remained significant after additional adjustment for brain pathologies (HR, 0.60; 95% CI, 0.42-0.86). The highest CR score tertile was associated with a reduction in dementia risk, even among participants with high Alzheimer disease pathology (HR, 0.57; 95% CI, 0.37-0.87) and any gross infarcts (HR, 0.34; 95% CI, 0.18-0.62). CONCLUSIONS AND RELEVANCE: High lifespan CR is associated with a reduction in dementia risk, even in the presence of high brain pathologies. Our findings highlight the importance of lifespan CR accumulation in dementia prevention.
Authors: Julie Gonneaud; Brigitte Landeau; Sophie Dautricourt; Vince D Calhoun; Robin de Flores; Géraldine Poisnel; Salma Bougacha; Valentin Ourry; Edelweiss Touron; Elizabeth Kuhn; Harriet Demintz-King; Natalie L Marchant; Denis Vivien; Vincent de la Sayette; Antoine Lutz; Gaël Chételat Journal: Alzheimers Res Ther Date: 2022-05-23 Impact factor: 8.823
Authors: Justina F Avila; Miguel Arce Rentería; Richard N Jones; Jet M J Vonk; Indira Turney; Ketlyne Sol; Dominika Seblova; Franchesca Arias; Tanisha Hill-Jarrett; Shellie-Anne Levy; Oanh Meyer; Annie M Racine; Sarah E Tom; Rebecca J Melrose; Kacie Deters; Luis D Medina; Carmen I Carrión; Mirella Díaz-Santos; DeAnnah R Byrd; Anthony Chesebro; Juliet Colon; Kay C Igwe; Benjamin Maas; Adam M Brickman; Nicole Schupf; Richard Mayeux; Jennifer J Manly Journal: Alzheimers Dement Date: 2020-08-22 Impact factor: 16.655
Authors: Ko Woon Kim; Sook Young Woo; Seonwoo Kim; Hyemin Jang; Yeshin Kim; Soo Hyun Cho; Si Eun Kim; Seung Joo Kim; Byoung-Soo Shin; Hee Jin Kim; Duk L Na; Sang Won Seo Journal: Sci Rep Date: 2020-10-08 Impact factor: 4.379
Authors: Tobias Möllers; Hannah Stocker; Laura Perna; Andreas Nabers; Dan Rujescu; Annette M Hartmann; Bernd Holleczek; Ben Schöttker; Klaus Gerwert; Hermann Brenner Journal: Alzheimers Dement (Amst) Date: 2021-02-10